Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Direct and indirect regulation of the tumor immune microenvironment by VEGF
Yuqing Zhang, Rolf A. Brekken
Journal of Leukocyte Biology (2022) Vol. 111, Iss. 6, pp. 1269-1286
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF
Seyedehdelaram Ghalehbandi, Jale Yüzügülen, Md Zahidul Islam Pranjol, et al.
European Journal of Pharmacology (2023) Vol. 949, pp. 175586-175586
Open Access | Times Cited: 136
Challenges in developing personalized neoantigen cancer vaccines
Peter D. Katsikis, Ken J. Ishii, Christopher Schliehe
Nature reviews. Immunology (2023) Vol. 24, Iss. 3, pp. 213-227
Closed Access | Times Cited: 91
VEGF signaling: Role in angiogenesis and beyond
Pallab Shaw, Shailendra Kumar Dhar Dwivedi, Resham Bhattacharya, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189079-189079
Closed Access | Times Cited: 57
Advances in research on the anti-tumor mechanism of Astragalus polysaccharides
Qian Yang, Dandan Meng, Qinyuan Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 25
Milestones in tumor vascularization and its therapeutic targeting
Michele De Palma, Douglas Hanahan
Nature Cancer (2024) Vol. 5, Iss. 6, pp. 827-843
Closed Access | Times Cited: 17
Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies
Anchal Pathak, Ajay Kumar Pal, Subhadeep Roy, et al.
Stem Cells International (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 16
Anlotinib may enhance the efficacy of anti-PD1 therapy by inhibiting the AKT pathway and promoting the apoptosis of CAFs in lung adenocarcinoma
Hui Tang, Tingting You, Hui Ge, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112053-112053
Closed Access | Times Cited: 9
Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous HCC
Shuling Chen, Changyi Liao, Huanjing Hu, et al.
Hepatology (2023) Vol. 79, Iss. 4, pp. 780-797
Closed Access | Times Cited: 20
Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma
Minglei Zhao, Hui Huang, Feng He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression
Hussein Sabit, Borros Arneth, Shaimaa Abdel-Ghany, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1666-1666
Open Access | Times Cited: 8
Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
Tingrui Zhang, Zongguang Tai, Fengze Miao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 372-396
Closed Access | Times Cited: 7
Drug resistance and tumor immune microenvironment: An overview of current understandings (Review)
Yan Liu, Jun Liang, Yanping Zhang, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 4
Open Access | Times Cited: 6
Predictive Biomarkers and Resistance Mechanisms of Checkpoint Inhibitors in Malignant Solid Tumors
Luciana Alexandra Pavelescu, Robert Mihai Enache, Oana Alexandra Roşu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9659-9659
Open Access | Times Cited: 6
Neuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk
Hua‐yang Fan, Xin‐hua Liang, Ya‐ling Tang
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 6
Diverse Neutrophil Functions in Cancer and Promising Neutrophil-Based Cancer Therapies
Khetam Sounbuli, Н. Л. Миронова, Л. А. Алексеева
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15827-15827
Open Access | Times Cited: 28
A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov
Jing Yang, Heming Kang, Liyang Lyu, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Potential therapeutic targets in myeloid cell therapy for overcoming chemoresistance and immune suppression in gastrointestinal tumors
Jiawei Fan, Jianshu Zhu, He Zhu, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 198, pp. 104362-104362
Open Access | Times Cited: 5
Aptamer-Based Probes for Cancer Diagnostics and Treatment
Xueqi Hu, Dongdong Zhang, Zheng Zeng, et al.
Life (2022) Vol. 12, Iss. 11, pp. 1937-1937
Open Access | Times Cited: 21
Antitumor effect of exopolysaccharide from Lactiplantibacillus plantarum WLPL09 on melanoma mice via regulating immunity and gut microbiota
Qian Wang, Bensheng Jiang, Min Wei, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127624-127624
Closed Access | Times Cited: 12
Targeting the Tumor Microenvironment in EGFR-Mutant Lung Cancer: Opportunities and Challenges
Jeong Uk Lim, Junyang Jung, Yeon Wook Kim, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 470-470
Open Access
Unveiling Novel Targets in Lung Tumors for Enhanced Radiotherapy Efficacy: A Comprehensive Review
Faris Anad Muhammad, Ayat Hussein Adhab, Morug Salih Mahdi, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access
The Role of Chemokine (C‐C Motif) Ligand 7 (CCL7) in Hepatocellular Carcinoma: Expression, Function, and Mechanisms
Yangkun Luo, Fei Wan, Zhao Zhang, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Angiogenesis in Glioblastoma—Treatment Approaches
Agnieszka Nowacka, Maciej Śniegocki, Wojciech Smuczyński, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 407-407
Open Access
Synergistic Strategies for Lung Cancer Immunotherapy: Combining Phytochemicals and Immune‐Checkpoint Inhibitors
Quan Gao, Hao Wu, Zhengjun Li, et al.
Phytotherapy Research (2025)
Closed Access
An inulin-type fructan CP-A from Codonopsis pilosula combined with 5-Fluorouracil alleviates colitis-associated tumorigenesis via inhibition of EGFR/AKT/ERK signaling pathway and regulation of intestinal flora
Jiangtao Zhou, Xuepeng Zhang, Changjian Wang, et al.
International Journal of Biological Macromolecules (2025), pp. 142655-142655
Closed Access
Page 1 - Next Page

Scroll to top